---
figid: PMC3929246__bctt-5-043Fig1
figtitle: Contribution of toll-like receptor signaling pathways to breast tumorigenesis
  and treatment
organisms:
- NA
pmcid: PMC3929246
filename: bctt-5-043Fig1.jpg
figlink: /pmc/articles/PMC3929246/figure/f1-bctt-5-043/
number: F1
caption: 'The toll-like receptor (TLR) signaling pathway is initiated via activation
  of TLRs, followed by adaptor complex formation, interleukin-1R-associated kinase
  (IRAK) and/or tumor necrosis factor receptor-associated factor 6 (TRAF6) activation
  to induce subsequent mitogen-activated protein kinase, nuclear factor-kappa B (NF-κB),
  and interferon-regulatory factor (IRF) activation, nuclear translocation, and regulation
  of pro- or anti-inflammatory gene expression.Abbreviations: AP-1, activator protein-1;
  CCL, β-chemokine ligand; CCR, β-chemokine receptor; CD14, cluster of differentiation
  14; CXCL, α-chemokine ligand; CXCR, α-chemokine receptor; IFN, interferon; IL, interleukin;
  IL-1R, interleukin-1 receptor; LPS, lipopolysaccharide; LTA, lipoteichoic acid;
  MD2, myeloid differentiation protein-2; MMPs, matrix metalloproteinases; MyD88,
  myeloid differentiation factor 88; PARP, poly-(ADP-ribose) polymerase; PGN, peptidoglycan;
  TIR, toll/interleukin receptor; TIRAP, toll/interleukin receptor homology domain
  adaptor protein; TLR, toll-like receptor; TNF, tumor necrosis factor; TRAM, toll/interleukin
  receptor-domain-containing adapter-inducing interferon-β-related adaptor molecule;
  TRIF, toll/interleukin receptor-domain-containing adapter-inducing interferon-β;
  TOLLIP, toll-interacting protein.'
papertitle: Contribution of toll-like receptor signaling pathways to breast tumorigenesis
  and treatment.
reftext: La Creis R Kidd, et al. Breast Cancer (Dove Med Press). 2013;5:43-51.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9483059
figid_alias: PMC3929246__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3929246__F1
ndex: c2046e4b-def7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3929246__bctt-5-043Fig1.html
  '@type': Dataset
  description: 'The toll-like receptor (TLR) signaling pathway is initiated via activation
    of TLRs, followed by adaptor complex formation, interleukin-1R-associated kinase
    (IRAK) and/or tumor necrosis factor receptor-associated factor 6 (TRAF6) activation
    to induce subsequent mitogen-activated protein kinase, nuclear factor-kappa B
    (NF-κB), and interferon-regulatory factor (IRF) activation, nuclear translocation,
    and regulation of pro- or anti-inflammatory gene expression.Abbreviations: AP-1,
    activator protein-1; CCL, β-chemokine ligand; CCR, β-chemokine receptor; CD14,
    cluster of differentiation 14; CXCL, α-chemokine ligand; CXCR, α-chemokine receptor;
    IFN, interferon; IL, interleukin; IL-1R, interleukin-1 receptor; LPS, lipopolysaccharide;
    LTA, lipoteichoic acid; MD2, myeloid differentiation protein-2; MMPs, matrix metalloproteinases;
    MyD88, myeloid differentiation factor 88; PARP, poly-(ADP-ribose) polymerase;
    PGN, peptidoglycan; TIR, toll/interleukin receptor; TIRAP, toll/interleukin receptor
    homology domain adaptor protein; TLR, toll-like receptor; TNF, tumor necrosis
    factor; TRAM, toll/interleukin receptor-domain-containing adapter-inducing interferon-β-related
    adaptor molecule; TRIF, toll/interleukin receptor-domain-containing adapter-inducing
    interferon-β; TOLLIP, toll-interacting protein.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LPA
  - IRF6
  - LY96
  - CD14
  - NDUFA2
  - IRAK4
  - IRAK1
  - TOLLIP
  - TRAF6
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - IRAK2
  - IRAK3
  - IRF3
  - NFKB1
  - IFNA1
  - IRF7
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - CRYGC
  - CRYGEP
  - CCL1
  - CCL2
  - CCL3L1
  - CCL3L3
  - CCL4L1
  - CCL4L2
  - CCL5
  - CCL7
  - CCL8
  - CCL11
  - CCL13
  - CCL14
  - CCL15
  - CCL16
  - CCL17
  - CCL18
  - CCL19
  - CCL20
  - CCL21
  - CCL22
  - CCL24
  - CCL25
  - CCL26
  - CCL27
  - CCL28
  - CXCL16
  - CXCL17
  - XCL1
  - XCL2
  - CCL3
  - CCL4
  - IL6
  - IL18
  - TLR7
  - TLR8
  - TLR9
  - TLR5
  - MYD88
  - TIRAP
  - TLR1
  - TLR2
  - TLR6
  - TLR4
  - TRAM1
  - TICAM2
  - TMED7-TICAM2
  - TRIM69
  - TICAM1
  - TLR3
---
